FDA Inspection 1244382 — American Red Cross Blood Services

American Red Cross Blood Services — FEI 3002571149

The FDA completed an inspection of American Red Cross Blood Services on June 14, 2024 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 14, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Boston, MA (United States)